The NASDAQ-listed medical device company Eyenovia (EYEN) announced the use of $50 million to purchase the decentralized exchange Hyperliquid platform token HYPE and will list this holding in the company treasury. (Background: Why did the Hyperliquid token HYPE and the open contracts soar to 'historical highs'?) (Supplementary background: Arthur Hayes: The altcoin season is just around the corner! Focusing on HYPE's ambition of a 50% monthly increase) The NASDAQ-listed medical device company Eyenovia (EYEN) announced last night (17th) the use of $50 million to purchase the decentralized exchange Hyperliquid platform token HYPE, and will include this holding in the company treasury. After the news broke, Google Finance data showed that Eyenovia's stock price responded by rising, briefly breaking $7, and at the time of writing reported at $6.97, closing with a gain of 134%. Why choose HYPE instead of Bitcoin? Eyenovia stated that in an inflationary environment, a diversified asset allocation is needed. Currently, corporate reserves are often primarily in Bitcoin, but this time the company locked in HYPE, which has no direct correlation with its business, primarily because Hyperliquid's on-chain perpetual futures volume has rapidly grown in recent months, and HYPE has jumped to fifth in open futures volume. The company’s management pointed out that "diversifying the treasury helps hedge against the decline in fiat purchasing power while capturing potential value appreciation in emerging blockchain ecosystems." This holding will be accounted in batches as long-term digital assets and will adopt a market value impairment accounting model. Additionally, according to the latest prices from Coingecko, HYPE is currently priced at $40.24, and Eyenovia's actions seem to have not brought much incentive, overall still following Bitcoin. Regulatory and financial challenges remain. Like any crypto layout, Eyenovia faces two major risks: first, price volatility, as HYPE's liquidity is lower than mainstream coins, leading to more severe fluctuations; second, regulatory uncertainty, as token positioning and trading compliance could change if the Trump administration adjusts the regulatory framework in 2025. Nevertheless, Eyenovia still chooses to invest heavily, showing that some traditional companies are willing to take on higher risks for potentially high-growth assets. Market observers expect that if HYPE performs strongly, other non-crypto industry companies may also consider following suit. Related reports $HYPE surged to $42, creating a historical high! Big brother Mahji realized profits, earning $6.5 million, whales heavily bought into Hyperliquid. Whales turning into small shrimp? James Wynn opened another Bitcoin long position but worth less than $20,000, supporting CZ's push for dark pool DEX: Can blow up Hyperliquid. CZ: I didn't call the shot! Aster's market share soared to 20%, competing with Hyperliquid for the top position in Perp DEX. "Listed company Eyenovia announced a $50 million investment in $HYPE, why choose Hyperliquid instead of Bitcoin?" This article was first published by BlockTempo (BlockTempo - the most influential blockchain news media).